The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Day One Biopharmaceuticals Inc’s current trading price is -55.06% away from its 52-week high, while its distance from the 52-week low is 3.05%. The stock’s price range for this period has been between $7.88 and $18.07 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.35 million for the day, a number notably higher than the average daily volume of 1.17 million over the last three months.
In terms of market performance, Day One Biopharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $18.07 on 05/01/24, and the lowest value was recorded at $7.88 on 03/11/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Day One Biopharmaceuticals Inc (DAWN) has experienced a quarterly decline of -38.58% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 823.00M and boasts a workforce of 181 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.63, with a change in price of -6.96. Similarly, Day One Biopharmaceuticals Inc recorded 1,156,421 in trading volume during the last 100 days, posting a change of -46.15%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for DAWN stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
DAWN Stock Stochastic Average
As of today, Day One Biopharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 4.25%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 5.12%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 14.00% and 14.74%, respectively.
DAWN Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant loss of -35.91% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -42.37%. Over the past 30 days, the price of DAWN has leaped by -33.06%. And in the last five days, it has fallen by -6.34%.
